Biochemical and Biophysical Research Communications
Regular ArticleCloning of the Human Sodium Iodide Symporter☆
References (0)
Cited by (472)
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
2021, Molecular Therapy OncolyticsTumor microenvironment affects exogenous sodium/iodide symporter expression
2021, Translational OncologyCitation Excerpt :After total thyroidectomy, the remaining NIS expression then allows for radioiodine ablation of metastases and residual thyroid tissue using 131I. After the identification of the NIS-encoding genes [9–11], iodide uptake could be evoked in non-thyroid cancer cells using gene therapy approaches. The resulting induced iodide uptake enabled noninvasive imaging of gene transfer monitoring and radioiodine ablation of targeted cells [12,13,14].
Perfluorooctane sulfonic acid, a persistent organic pollutant, inhibits iodide accumulation by thyroid follicular cells in vitro
2020, Molecular and Cellular EndocrinologyHigh temperature driven transformation of iodine species in AFI and AEL channels: A comparative study
2019, Microporous and Mesoporous Materials
- ☆
The nucleotide sequence of the human sodium iodide symporter reported in this paper has been submitted to the Genbank database. The accession number assigned to this sequence is U66088.
Abbreviations used: hNIS, human sodium iodide symporter; rNIS, rat sodium iodide symporter; RT-PCR, reverse-transcription polymerase chain reaction.
- 1
Correspondence to Dr. Sissy M. Jhiang, 302 Hamilton Hall, 1645 Neil Ave., Columbus, OH 43210. Fax: 614-292-4888.